Skip to content
Home/Companies/BioTech, Greentech/Amoéba
Amoéba

Amoéba

BioTech, Greentech·France·Exited 2015·Held 4yr
Entry
2011
Hold
4yr
Exit
2015

Who owns Amoéba?

Amoéba was owned by Evolem through Evolem Start (2015 vintage) from 2011 to 2015, exited via IPO.

Hand-verified · updated 2026-04-21

Evolem
Investor
Evolem
Evolem Start · 2015 · VC

Key facts

HQFrance
SectorBioTech, Greentech
Websiteamoeba-nature.com
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2015

More from Evolem Start

Other portfolio companies in the same fund.

Cevilog Vision System
Cevilog Vision System
Active
IndustrialsFrance· 2026
Ed
Active
EdTechFrance· 2025
Fungu’it
Active
FoodTechFrance· 2025
Kimialys
Active
MedTechFrance· 2025
Mediflash
Active
HR TechFrance· 2025
Sirius Neosight
Sirius Neosight
Active
HealthTechFrance· 2025

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Amoéba

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Amoéba?

0 strategic and 120financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Amoéba.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue